Verapamil Hydrochloride
- Product NDC
- 70934-214
- 11-digit product format
- 709340214
- Labeler code
- 70934
- Product ID
- 70934-214_b81484c6-7a08-1caa-e053-2995a90a7b82
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA074587
- Marketing category
- ANDA
- Marketing start
- 2018-12-27
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-214-30 | 70934021430 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-214-30) | 2018-12-27 | 0000-00-00 | No | No | Current |